Oxtriphylline

CHEMBL1200434 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

283.3 g/mol

LogP

—

Phase

4

A bronchodilator related to theophylline, used to open up the airways in conditions such as asthma and chronic obstructive pulmonary disease. It relaxes the muscles around the airways to make breathing easier.

Moleküler Ağırlık

283,3300 g/mol

TPSA

91,60 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

C[N+](C)(C)CCO.Cn1c(=O)c2[n-]cnc2n(C)c1=O

InChI

InChI=1S/C7H8N4O2.C5H14NO/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;1-6(2,3)4-5-7/h3H,1-2H3,(H,8,9,12);7H,4-5H2,1-3H3/q;+1/p-1

Molecular Formula

C12H21N5O3

HBD / HBA

1 / 4

Döndürülebilir Bağlar

2

Ağır Atomlar

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A bronchodilator related to theophylline, used to open up the airways in conditions such as asthma and chronic obstructive pulmonary disease. It relaxes the muscles around the airways to make breathing easier.

Yes, Oxtriphylline is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200434. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 656652. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Oxtriphylline PillFYI'da

Yapı

Hızlı Veriler

Formül: C12H21N5O3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.